Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Thorax 2006;61:1096-1097; doi:10.1136/thx.2004.029819
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arish, N
Right arrow Articles by Rokach, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arish, N
Right arrow Articles by Rokach, A

CASE REPORT

Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins

N Arish1, R Eldor1, Y Fellig2, N Bogot3, U Laxer4, U Izhar5, A Rokach4

1 Department of Medicine C, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
2 Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
3 Institute of Radiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
4 Institute of Pulmonology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
5 Department of Cardiothoracic Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Correspondence to:
Correspondence to:
Dr A Rokach
Institute of Pulmonology, Hadassah-Hebrew University Medical Center, P O Box 12000, Jerusalem, Israel 91120; arielr{at}hadassah.org.il

Lymphocytic interstitial pneumonia (LIP) is a rare form of interstitial lung disease. A few case reports have described an association with common variable immunodeficiency (CVID). Corticosteroids are usually used to treat symptomatic patients but their efficacy has never been studied in a controlled trial. We describe a patient with LIP and CVID who was treated monthly with intravenous immunoglobulins (IVIG) without steroids. The patient improved dramatically. We believe that, in selected cases of LIP and immunodeficiency, IVIG given monthly should be considered as the only treatment without adding steroids.


Abbreviations: BOOP, bronchiolitis obliterans organising pneumonia; CVID, common variable immunodeficiency; IVIG, intravenous immunoglobulins; LIP, lymphocytic interstitial pneumonia

Keywords: interstitial lung disease; lymphocytic interstitial pneumonia; common variable immunodeficiency; immunoglobulins; corticosteroids




This article has been cited by other articles:


Home page
ThoraxHome page
M A Valdivia-Arenas and N Sood
Lymphocytic interstitial pneumonia and pulmonary embolism in a patient with tetralogy of Fallot and common variable immunodeficiency: is there any link?
Thorax, May 1, 2008; 63(5): 470 - 471.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Thoracic Society